9,409 Shares in Cardinal Health, Inc. $CAH Bought by Nations Financial Group Inc. IA ADV

Nations Financial Group Inc. IA ADV purchased a new stake in Cardinal Health, Inc. (NYSE:CAH) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 9,409 shares of the company’s stock, valued at approximately $1,988,000.

Other hedge funds have also recently bought and sold shares of the company. Stance Capital LLC grew its stake in shares of Cardinal Health by 9.1% in the 4th quarter. Stance Capital LLC now owns 20,213 shares of the company’s stock worth $4,154,000 after acquiring an additional 1,692 shares in the last quarter. World Investment Advisors raised its holdings in shares of Cardinal Health by 42.2% in the fourth quarter. World Investment Advisors now owns 7,412 shares of the company’s stock valued at $1,523,000 after purchasing an additional 2,200 shares during the last quarter. Corient Private Wealth LLC lifted its position in shares of Cardinal Health by 5.7% during the fourth quarter. Corient Private Wealth LLC now owns 86,229 shares of the company’s stock valued at $17,722,000 after purchasing an additional 4,636 shares in the last quarter. SHP Wealth Management bought a new position in shares of Cardinal Health during the fourth quarter valued at about $128,000. Finally, Reflection Asset Management purchased a new position in Cardinal Health during the fourth quarter worth about $47,000. 87.17% of the stock is owned by hedge funds and other institutional investors.

Cardinal Health Stock Performance

NYSE CAH opened at $222.08 on Monday. The company has a market capitalization of $52.01 billion, a PE ratio of 33.96, a price-to-earnings-growth ratio of 1.21 and a beta of 0.52. Cardinal Health, Inc. has a 52-week low of $137.75 and a 52-week high of $233.60. The company has a 50-day simple moving average of $204.34 and a 200 day simple moving average of $209.28.

Cardinal Health (NYSE:CAH) last released its earnings results on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, beating analysts’ consensus estimates of $2.79 by $0.38. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The firm had revenue of $60.94 billion for the quarter, compared to analysts’ expectations of $62.10 billion. During the same period in the previous year, the company earned $2.35 earnings per share. The company’s quarterly revenue was up 11.0% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. As a group, analysts forecast that Cardinal Health, Inc. will post 10.76 EPS for the current fiscal year.

Cardinal Health Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st will be paid a $0.5158 dividend. The ex-dividend date is Wednesday, July 1st. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. This represents a $2.06 annualized dividend and a yield of 0.9%. Cardinal Health’s dividend payout ratio (DPR) is currently 31.19%.

Analyst Ratings Changes

A number of equities research analysts have issued reports on the stock. William Blair began coverage on shares of Cardinal Health in a research report on Tuesday, April 28th. They issued an “outperform” rating for the company. JPMorgan Chase & Co. dropped their target price on shares of Cardinal Health from $243.00 to $215.00 and set a “neutral” rating on the stock in a research report on Monday, May 4th. Citigroup cut their target price on Cardinal Health from $249.00 to $245.00 and set a “buy” rating on the stock in a research note on Friday, May 1st. Zacks Research lowered Cardinal Health from a “strong-buy” rating to a “hold” rating in a report on Friday, June 12th. Finally, Leerink Partners reiterated an “outperform” rating and set a $275.00 price target on shares of Cardinal Health in a report on Monday, March 9th. Fourteen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $246.93.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.